The Gaming for Medical Education Research (G4MER) Program

Sponsor
The University of New South Wales (Other)
Overall Status
Unknown status
CT.gov ID
NCT03666468
Collaborator
(none)
264
1
3
57.9
4.6

Study Details

Study Description

Brief Summary

The "G4MER" Program aims to investigate whether serious games add value to medical education in comparison to an online learning package or clinical practice guidelines. The investigators will perform a series of investigator-blinded randomised control trials on doctors, nurses, and medical students at Sydney Children's Hospital. Participants will be given access to their randomly allocated intervention for 8 weeks or 5 days, and will be assessed using multiple choice questions (MCQ) and two observed structure clinical examination (OSCE) stations. Participant attitudes will also be assessed through a mixed-methods questionnaire.

Condition or Disease Intervention/Treatment Phase
  • Other: PlayMed
  • Other: Online Package
  • Other: Paper Guidelines
N/A

Detailed Description

The "G4MER" Program aims to perform a series of randomised control trials on different groups at Sydney Children's Hospital:

  1. Study 1A (Formerly titled "Serious Games in Medical Education - a Randomised Control Trial") is already underway and involves Phase 3 medical students at UNSW having 8 weeks access to the game, an Online Package (OP) or NSW State Guidelines on Asthma and Seizure management. Students are then assessed using multiple choice questions (MCQ) and two observed structure clinical examination (OSCE) stations (detailed below).

  2. Study 1B is also a randomised control trial similar in design to Study 1A, however it will involve doctors and nurses employed at Sydney Children's Hospital. PlayMed will be compared against the HETI Learning Path Paediatric Clinical Practice Guidelines (Online Package for staff).

  3. Studies 2A and 2B are identical to Studies 1A and 1B respectively except participants will have 2 hours access to their educational tool. Participants will then immediately undergo the same assessment using multiple choice questions (MCQ) and two observed structure clinical examination (OSCE) stations The proposed study designs are all blinded randomised control trials. Participants may only be involved in Study 1 or Study 2, not both.

Administration

Studies 1A and 1B Participants allocated to the game and to the OP will be given the appropriate access for 8 weeks (instructions provided in the study envelope). Participants allocated to the guidelines will receive a print-out of the guidelines. Participants will be encouraged to engage with their additional educational tool as often as they wish during their eight weeks. In the 8th last week participants will have their knowledge and clinical performance assessed as outlined below.

Studies 2A and 2B Participants allocated to the game, OP and guidelines will be given 2 hours to utilise their assigned teaching tool. Two hours was selected as an appropriate time-frame in which participants would be able complete all cases of the game or online package, or read through the guidelines. Furthermore, it was chosen as it is more pragmatic and better at assessing short-term retention. Computers will be provided for participants to access the game and OP. The guidelines will be printed for participants to read. Participants will then immediately have their knowledge and clinical performance assess as outlined below.

Assessment

Studies 1A, 1B, 2A and 2B Participants will be assessed for knowledge acquisition and clinical performance. Participant knowledge will be assessed using 10 multiple choice questions (MCQ). Participant clinical skills will be assessed via an observed structured clinical examination (OSCE) administered in the simulation laboratory (immediately after the knowledge test); participants will be tested across two clinical scenarios. Strict marking criteria will be used to ensure standardisation.

Study Design

Study Type:
Interventional
Anticipated Enrollment :
264 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Intervention Model Description:
3 groups3 groups
Masking:
Double (Investigator, Outcomes Assessor)
Primary Purpose:
Treatment
Official Title:
Gaming for Medical Education Research Program: An Investigator-blinded, Randomised Controlled Trial on Serious Games for Doctors, Nurses and Students.
Actual Study Start Date :
Jul 3, 2017
Anticipated Primary Completion Date :
Feb 28, 2022
Anticipated Study Completion Date :
Apr 30, 2022

Arms and Interventions

Arm Intervention/Treatment
Experimental: PlayMed

PlayMed, a highly immersive role-playing computer game - Focus on Paediatric Asthma and Seizure management

Other: PlayMed
A highly immersive role-playing computer game focused on Paediatric Asthma and Seizure management

Active Comparator: Online Package (OP)

Online package (OP) of NSW Health Guidelines - Focus on Paediatric Asthma and Seizure management

Other: Online Package
Online package (OP) of NSW Health Guidelines focused on Paediatric Asthma and Seizure management

Placebo Comparator: Paper Guidelines

Paper NSW Health Guidelines - Focus on Paediatric Asthma and Seizure management

Other: Paper Guidelines
Paper NSW Health Guideline focused on Paediatric Asthma and Seizure management

Outcome Measures

Primary Outcome Measures

  1. Multiple choice quiz score [Post-intervention assessment; 8 weeks (Study 1A and 1B) or 2 hours (Study 2A and 2B).]

    A paper-based assessment using multiple choice questions designed to test knowledge acquisition for asthma and seizure management. For Studies 1A and 1B, scale 0 to 10, higher is better performance. Studies 2A and 2B, scale from 0 to 15, higher is better.

  2. Asthma observed structured clinical examination (OSCE) score [Post-intervention assessment; 8 weeks (Study 1A and 1B) or 2 hours (Study 2A and 2B).]

    An OSCE administered in a high-fidelity simulation lab. A child with an exacerbation of asthma will be presented and the management required will need to be implemented by the participant. For Studies 1A and 1B, subscale from 0 to 15, higher is better, with scores summed with Outcome 3. Studies 2A and 2B, subscale from 0 to 25, higher is better, with scores summed with Outcome 3.

  3. Seizure observed structured clinical examination (OSCE) scoresimulation lab) [Post-intervention assessment; 8 weeks (Study 1A and 1B) or 2 hours (Study 2A and 2B).]

    An OSCE administered in a high-fidelity simulation lab. A child with a seizure will be presented and the management required will need to be implemented by the participant. For Studies 1A and 1B, subscale from 0 to 15, higher is better, with scores summed with Outcome 3. Studies 2A and 2B, subscale from 0 to 25, higher is better, with scores summed with Outcome 2.

Secondary Outcome Measures

  1. Participant attitudes towards educational intervention [Post-intervention assessment; 8 weeks (Study 1A and 1B) or 2 hours (Study 2A and 2B).]

    Mixed-methods analysis survey. 5-point Likert scale from "Strongly Agree" to "Strongly Disagree".

  2. Time to specific actions in OSCE scenarios [Post-intervention assessment; 8 weeks (Study 1A and 1B) or 2 hours (Study 2A and 2B).]

    E.g. calling for help, oxygen supplementation, salbutamol, anti-epileptic drug

  3. Anti-epileptic medication(s) administered at correct time during OSCE scenario [Post-intervention assessment; 8 weeks (Study 1A and 1B) or 2 hours (Study 2A and 2B).]

    E.g. Midazolam or diazepam correctly administered at 5 minutes of seizure activity (yes/no).

Eligibility Criteria

Criteria

Ages Eligible for Study:
20 Years to 99 Years
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
Yes
Inclusion Criteria:
  • Studies 1A and 2A Phase 2 or 3 medical students at UNSW who are enrolled in the Children's Health Course will be eligible

  • Studies 1B and 2B Doctors and nurses employed at Sydney Children's Hospital.

Exclusion Criteria:
  • Studies 1A and 2A Medical students not actively enrolled at UNSW

  • Studies 1B and 2B Doctors and nurses not actively employed at Sydney Children's Hospital.

Contacts and Locations

Locations

Site City State Country Postal Code
1 Sydney Children's Hospital Randwick New South Wales Australia 2031

Sponsors and Collaborators

  • The University of New South Wales

Investigators

  • Principal Investigator: Michael J Coffey, BMed MD, The University of New South Wales

Study Documents (Full-Text)

More Information

Publications

None provided.
Responsible Party:
Dr Michael Coffey, Principal Investigator, The University of New South Wales
ClinicalTrials.gov Identifier:
NCT03666468
Other Study ID Numbers:
  • HC17160-LNR/17/SCHN/194
First Posted:
Sep 11, 2018
Last Update Posted:
Jul 31, 2019
Last Verified:
Jul 1, 2019
Individual Participant Data (IPD) Sharing Statement:
No
Plan to Share IPD:
No
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No

Study Results

No Results Posted as of Jul 31, 2019